There are errors in [Table 1](#pone.0207561.t001){ref-type="table"}. There are multiple incorrect abbreviations in the first column. Please see the corrected [Table 1](#pone.0207561.t001){ref-type="table"} here.
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###### Baseline characteristics of CKD stage 3--4, CKD stage 5-ESRD, and non-CKD groups.
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  --------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristi*c*s                           Non-CKD group (A)   CKD stage\       CKD stage\    P value    Post-hoc[†](#t001fn002){ref-type="table-fn"}
                                                                  3--4 group (B)   5-ESRD (C)               
  ------------------------------------------- ------------------- ---------------- ------------- ---------- ----------------------------------------------
  Total                                       8213 (90.2%)        730 (8.0%)       166 (1.8%)               

  Mean age (years)                            58.08±14.15         72.30±12.10      62.45±13.20   0.0001     A\<C\<B

  Gender (Male %)                             4115 (50.1%)        331 (45.3%)      80 (48.1%)    0.044      A\>B\>C

  Presence of chronic illness (% by groups)                                                                 

  HTN                                         1864 (22.7%)        413 (56.6%)      95 (57.2%)    \<0.0001   A\<B\<C

  DM                                          1462 (17.8%)        300 (41.1%)      83 (50.0%)    \<0.0001   A\<B\<C

  CVD                                         987 (12.0%)         216 (29.6%)      51 (30.7%)    \<0.0001   A\<B\<C

  LC                                          179 (2.2%)          28 (3.8%)        9 (5.4%)      0.001      A\<B\<C

  CHF                                         109 (1.3%)          70 (9.6%)        17(10.2%)     0.0001     A\<B\<C

  COPD                                        78 (0.9%)           17 (2.3%)        2 (1.2%)      0.002      A\<C\<B

  eGFR (ml/min/1.73 m^2^)                     92.78±14.86         44.49±12.06      7.33±3.19     \<0.0001   C\<B\<A
  --------------------------------------------------------------------------------------------------------------------------------------------------------

CKD, chronic kidney disease; ESRD, end-stage renal disease; eGFR, estimated glomerular filtration rate; HTN, hypertension; DM, diabetes mellitus; CVD, cardiovascular disease; LC, liver cirrhosis; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease. eGFR was calculated using CKD-EPI formula. Age and eGFR are presented as mean ± standard deviation (SD). Nominal data are presented as percentages

†p-value by student t-test or chi-squared/fisher exact test and adjusted by bonferroni correction
